143 related articles for article (PubMed ID: 29614980)
1. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
Girardi DM; de Lima MA; Pereira GCB; Negrão MV; López RVM; Capareli FC; Sabbaga J; Hoff PMG
BMC Cancer; 2018 Apr; 18(1):378. PubMed ID: 29614980
[TBL] [Abstract][Full Text] [Related]
2. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
4. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.
Ozden S; Ozgen Z; Ozyurt H; Gemici C; Yaprak G; Tepetam H; Mayadagli A
World J Gastroenterol; 2015 Jan; 21(4):1222-33. PubMed ID: 25632196
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy.
Jácome AA; Wohnrath DR; Scapulatempo Neto C; Fregnani JH; Quinto AL; Oliveira AT; Vazquez VL; Fava G; Martinez EZ; Santos JS
Gastric Cancer; 2013 Apr; 16(2):233-8. PubMed ID: 22740060
[TBL] [Abstract][Full Text] [Related]
7. D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.
Peng J; Wei Y; Zhou F; Dai J; Zhong Y; Xie C; Qin Y; Gong J; Xiong B; Zhou Y
Cancer Med; 2016 Oct; 5(10):2773-2780. PubMed ID: 27666138
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis.
Mokdad AA; Yopp AC; Polanco PM; Mansour JC; Reznik SI; Heitjan DF; Choti MA; Minter RR; Wang SC; Porembka MR
JAMA Oncol; 2018 Jan; 4(1):31-38. PubMed ID: 28975352
[TBL] [Abstract][Full Text] [Related]
11. Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis.
Li N; Xiang X; Zhao D; Wang X; Tang Y; Chi Y; Yang L; Jiang L; Jiang J; Shi J; Liu W; Fang H; Tang Y; Chen B; Lu N; Jing H; Qi S; Wang S; Liu Y; Song Y; Li Y; Zhang L; Jin J
BMC Cancer; 2022 Feb; 22(1):212. PubMed ID: 35219300
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.
Allen CJ; Pointer DT; Blumenthaler AN; Mehta RJ; Hoffe SE; Minsky BD; Smith GL; Blum M; Mansfield PF; Ikoma N; Das P; Ajani J; Dineen SP; Fleming JB; Badgwell BD; Pimiento JM
Ann Surg; 2021 Oct; 274(4):544-548. PubMed ID: 34132693
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario.
Kapoor R; Dracham CB; G Y S; Khosla D; Dey T; Elangovan A; Madan R; Yadav BS; Kumar N
J Gastrointest Cancer; 2021 Jun; 52(2):616-624. PubMed ID: 32535755
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis.
Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y
Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253
[TBL] [Abstract][Full Text] [Related]
15. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
16. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
18. Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection--do N3 patients benefit from additional radiation?
Fan M; Li G; Shen L; Zhang H; Liang L; Zhang Z
Br J Radiol; 2016; 89(1059):20150758. PubMed ID: 26728420
[TBL] [Abstract][Full Text] [Related]
19. Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
Ann Surg Oncol; 2022 Oct; 29(11):6962-6975. PubMed ID: 35723792
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent.
Turanli S; Atalay C; Berberoglu U; Gulben K
J Cancer Res Ther; 2015; 11(2):369-74. PubMed ID: 26148602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]